Given the critical role of IGF-I in cancer, such putative activities of IGF-I Ec peptide could comprise an important potential for illuminating the mechanisms of controlling PCa development and/or progression and for defining candidate targets for therapeutic intervention. This evidence concerns the gene IGF1 and posterior cortical atrophy.